Peanut Sublingual Immunotherapy (SLIT)-Tablet for Treatment of Peanut Allergy

Recruiting

Phase 1

Phase 2

Peanut Sublingual Immunotherapy (SLIT)-Tablet for Treatment of Peanut Allergy

Sponsor:

ALK-Abelló A/S

Code:

NCT05440643

Conditions

Peanut Allergy

Eligibility Criteria

Sex: All

Age: 4 - 65

Healthy Volunteers: Not accepted

Interventions

Peanut SLIT-tablet

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-16. This information was provided to ClinicalTrials.gov by ALK-Abelló A/S on 2025-05-25.